Ajax-Loading

Kyowa Kirin Co Ltd - End Period Cash Flow

Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Trillions.

The item "End-Period-Cash-Flow" stands at 0.99 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 03/31/2021.

Kyowa Kirin Co Ltd's second quarter result of 0.2346 Trillion JPY for the item "End Period Cash Flow" represents an increase of 9.44 percent compared to it's first quarter result.

Also, Kyowa Kirin Co Ltd's second quarter result of 0.2346 Trillion JPY for the item "End Period Cash Flow" represents a decrease of -24.60 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 0.99 Trillion JPY for the item "End Period Cash Flow" represents a decrease of -7.18 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -30.75 percent compared to the value the year prior.
The 1 year change in percent is -30.75.
The 3 year change in percent is -25.67.
The 5 year change in percent is 157.61.

The Serie's long term average value is 0.688 Trillion Japanese Yens. It's latest available value, on 06/30/2025, is 43.94 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 06/30/2025, is +7,471.02%.
The Serie's change in percent from it's maximum value, on 12/31/2023, to it's latest available value, on 06/30/2025, is -34.10%.

End Period Cash Flow for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - End Period Cash Flow905,699,262,464.00
LogoJohnson & Johnson - End Period Cash Flow486,508,953,600.00
LogoAbbVie Inc - End Period Cash Flow399,570,305,024.00
LogoRoche Holding AG - End Period Cash Flow317,433,206,677.55
LogoAstraZeneca PLC - End Period Cash Flow280,205,508,085.11